Showing results (4221-4230 of 11,108) with videos related to
Sort By:
Pageof 1,111
Journal of the National Cancer Institute|August 19, 2004
Clustering of gene hypermethylation associated with clinical risk groups in neuroblastomaMiguel Alaminos, Veronica Davalos, Nai-Kong V Cheung, et al.Journal of the National Cancer Institute|August 19, 2004
Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasisEvgeny Edovitsky, Michael Elkin, Eyal Zcharia, et al.Journal of the National Cancer Institute|August 19, 2004
H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancerFredrik Lindmark, S Lilly Zheng, Fredrik Wiklund, et al.Journal of the National Cancer Institute|July 9, 2004
Phase I trial design for solid tumor studies of targeted, non-cytotoxic agents: theory and practiceWendy R Parulekar, Elizabeth A EisenhauerJournal of the National Cancer Institute|April 15, 1992
Quality-of-life assessment in cancer treatment protocols: research issues in protocol developmentC C Gotay, E L Korn, M S McCabe, et al.Journal of the National Cancer Institute|March 3, 2005
Are breast density and bone mineral density independent risk factors for breast cancer?Karla Kerlikowske, John Shepherd, Jennifer Creasman, et al.Journal of the National Cancer Institute|March 3, 2005
Serum alpha-tocopherol and gamma-tocopherol in relation to prostate cancer risk in a prospective studyStephanie J Weinstein, Margaret E Wright, Pirjo Pietinen, et al.Journal of the National Cancer Institute|February 17, 2005
Do increases in the market share of managed care influence quality of cancer care in the fee-for-service sector?Nancy L Keating, Mary Beth Landrum, Ellen Meara, et al.Journal of the National Cancer Institute|January 22, 2004
Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral breast tumor recurrence and mortalityVincent Vinh-Hung, Claire VerschraegenJournal of the National Cancer Institute|January 22, 2004
Circulating DNA microsatellites: molecular determinants of response to biochemotherapy in patients with metastatic melanomaBret Taback, Steven J O'Day, Peter D Boasberg, et al.Pageof 1,111